ESR1 and breast carcinoma: Clinical studies suggest receptor conversion of ERα from negative to positive in the course of disease progression in distant breast cancer metastases (Schrijver et al., 2018; Aurilio et al., 2013; Chang et al., 2011; Hoefnagel, 2013; Bernsdorf, 2011).